Eli Lilly’s experimental pill for weight loss helped people lose an average of 15% of their body weight after 36 weeks on the highest dose in a midstage trial
The drug, orforglipron, had similar side effects as others in the class, known as GLP-1 receptor agonists: primarily gastrointestinal events like nausea, constipation and vomiting, researchers reported in a study published Friday in the New England Journal of Medicine. Results from the Lilly-funded trial were also presented at the American Diabetes Association conference in San Diego. Currently approved medicines for weight loss like Novo Nordisk’s Wegovy are given as once-weekly injections.
Participants on the medicine also had positive effects on levels of triglycerides and cholesterol, as well as systolic blood pressure, or the measure of pressure when the heart beats. There was no meaningful change in diastolic blood pressure, measuring pressure when the heart rests between beats. Side effects including nausea, constipation, vomiting and diarrhea were most common, the study showed.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Motorcyclist accused of shooting woman in the face on I-15A man was arrested Wednesday and accused of shooting another driver in the face on the freeway earlier this month.
Lire la suite »
Norway central bank raises rate to 15-year high, with more to comeNorway's central bank raised its key policy rate by 50 basis points to 3.75% on Thursday in a bid to curb inflation.
Lire la suite »
First Mover Americas: BTC Crosses $30K and Bitcoin Layer 2 Stacks Networks Gains 15%Bitcoin extended its rally on Thursday after surpassing $30,000 for the second time this year the day before; Stacks Network's STX token gained 15%. LedesmaLyllah and godbole17 report.
Lire la suite »
The 15 biggest NBA Draft busts of all time — and where they are nowIt’s one thing to make a bad draft pick. It’s another to potentially set your franchise back a decade in doing so.
Lire la suite »